| Released | Contributor | Author | Title | Pages | Price |
| 26-Nov-2009 | Pechala's Reports | Lubomir Pechala | BIODEL INC (BIOD=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 25-Nov-2009 | Zacks Investment Research Inc. |
N/A
| BIODEL INC (BIOD) Zacks Company Snapshot | 1 |
$10 |
| 24-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Biotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 18 new Laggards. | 58 |
$20 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for BIOD | 13 |
$25 |
| 23-Nov-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 |
| 21-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| Biodel Inc | 5 |
$25 |
| 20-Nov-2009 | Pechala's Reports | Frantisek Pechala | BIODEL CP (BIOD=US) 12-months forecast | 1 |
$15 |
| 20-Nov-2009 | Pechala's Reports | Lubomir Pechala | BIODEL CP (BIOD=US) 2-weeks forecast | 1 |
$10 |
| 19-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ADLR , BIOD , INFI , JAV , KERX , MBRK , NGSX , SNTA -- DRUGS | 3 |
$4 |
0.29% Nasdaq 
Research Reports
